Medtronic spacer
Medtronic
Medtronic
Medtronic Home > Information for Physicians > Pain > Neurostimulation > Proven benefits
  Neurostimulation
 

Neurostimulation with the SynergyT System

 

Who can benefit from Neurostimulation ?

 

Spinal Cord Stimulation with SynergyT

 

Proven benefits

 

Patient selection

 

SynergyT System

 

Important safety information

 

FAQ

Medtronic
Medtronic

Medtronic
Medtronic

Proven benefits

  • Good to excellent long-term pain relief
    59% of 189 patients that included FBS, CRPS Type I and PVD sufferers reported good-to-excellent pain relief with a mean follow-up of 66 months (5.5 years) [1]

     
  • 52% of 171 patients with a mean follow-up of up to 7 years had at least 50% sustained pain relief [2]

     
  • A recent review suggests that SCS may produce substantial and long-lasting pain relief
    in 60-70% of CRPS patients [3]

     
  • 78% of patients that included lumbosacral spine surgery failures (FBS), CRPS Type I and
    PVD sufferers, with a mean follow-up of 19 months, considered their outcome to be good
    or very good [4]
 
  • Early treatment produces better results
    - Reducing the delay between spinal surgery and implantation to 3 years increases
       the success rate to 93%; increased from 9% in FBS patients who had >12 years
       delay between surgery and implantation [1]
    - Better results than re-operation in FBS patients who have not benefited from
       1 or more laminectomies [8]


  • Enhanced performance of activities of daily living
    Improved sleep, increased ability to participate in social activities, reduction in
    analgesic use [5,2,6,7]
  • Documented patient satisfaction
    Majority of patients would have SynergyT implanted again, would recommend
    it to others, and still use their system in a 5-year follow-up [8,4]
  • Cost effective
    - SCS therapy reduces patients' needs for medical care, leading to cost savings
       over conservative treatment [9,10]
    - SCS treatment can pay for itself in 2.1 years (average 5.5 years) [9]
    - A cost-analysis model on CRPS SCS patients found substantial cost savings
       over a lifetime analysis vs physical therapy [11]
  • Fewer side-effects
    Complications associated with implant are harmless and infrequent [5]

References

1. Kumar K. Surgical Neurology 1998; 50:110-121
2 North RB. Neurosurgery 1991; 28:692-699
3. Meyerson BA. Acta Anaesth Scand 2001; 45:1108-1113
4. Segal R. Neurological Research 1998; 20:391-396
5. Burchiel KJ. Spine 1996; 21:2786-94
6. Van Buyten. J Neuromodulation 1999; 2:258-265
7. Ohnmeiss DD. Spine J 2001; 1:358-363
8. North RB. Neurosurgery 1993; 32:384-394
9. Bell GK. J Pain Sympt Manage 1997; 13:286-295
10 North RB. J Neursurg 1997; 86 Abstract 748
11 Kemler MA. N Engl J Med 2000; 24:1811



back
 

top
 

Privacy Statement Terms of Use Medtronic Footer